| 标题 |
Phase 3 Randomized Study of Daratumumab Plus Lenalidomide and Dexamethasone (D-Rd) Versus Lenalidomide and Dexamethasone (Rd) in Patients with Newly Diagnosed Multiple Myeloma (NDMM) Ineligible for Transplant (MAIA) |
| 网址 | |
| DOI |
10.1182/blood-2018-120737
doi
|
| 其它 |
期刊:Blood 作者:Thierry Facon; Shaji K. Kumar; Torben Plesner; Robert Z. Orlowski; Philippe Moreau; et al 出版日期:2019-10-10 |
| 求助人 | |
| 下载 | 求助已完成,仅限求助人下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)